Lupin submits Press Release

08 Mar 2025 Evaluate

Lupin has submitted a Press Release as regards, launch of Rivaroxaban Tablets USP, 2.5 mg, following the final approval from the U.S. FDA for the Company’s Abbreviated New Drug Application.

The above information is a part of company’s filings submitted to BSE.


Lupin Share Price

2114.05 24.40 (1.17%)
17-Dec-2025 11:27 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1775.00
Dr. Reddys Lab 1276.70
Cipla 1494.10
Zydus Lifesciences 917.20
Lupin 2114.05
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×